Related Experiment Videos
Pharmacokinetics of phenobarbitone in protein energy malnutrition
Insights
Malnourished children exhibit significantly prolonged phenobarbitone elimination half-life and higher bioavailability compared to healthy children. Dosage adjustments are recommended for phenobarbitone in pediatric malnutrition.
Area of Science:
- Pharmacokinetics
- Pediatric Medicine
- Nutritional Science
Background:
- Phenobarbitone is a widely used anticonvulsant in pediatric populations.
- Nutritional status can significantly impact drug metabolism and elimination.
- Understanding drug kinetics in malnourished children is crucial for safe and effective treatment.
Purpose of the Study:
- To investigate and compare the pharmacokinetics of phenobarbitone in malnourished versus healthy children.
- To determine the impact of protein-energy malnutrition on phenobarbitone absorption, distribution, metabolism, and excretion.
Main Methods:
- A single oral dose of phenobarbitone (approximately 7.0 mg/kg) was administered to both malnourished and healthy children.
- Serum phenobarbitone concentrations were measured using a spectrophotometric method.
- Key pharmacokinetic parameters including elimination half-life (t1/2) and time to maximum concentration (tmax) were analyzed.
Main Results:
- The elimination half-life of phenobarbitone was significantly longer in malnourished children (58.9 ± 9.5 h) compared to healthy children (30.15 ± 6.1 h).
- Time to maximum concentration (tmax) was prolonged in the malnutrition group, indicating slower drug absorption.
- Systemic bioavailability of phenobarbitone was found to be higher in children with protein-energy malnutrition.
Conclusions:
- Protein-energy malnutrition substantially alters phenobarbitone pharmacokinetics in children.
- Altered absorption and prolonged elimination necessitate modifications to standard phenobarbitone dosage regimens in malnourished pediatric patients.
- Further research into optimized dosing strategies for phenobarbitone in pediatric malnutrition is warranted.
Abstract:
Phenobarbitone kinetics was studied in malnourished and normal children after single oral dose of approximately 7.0 mg/kg. Estimation of serum phenobarbitone concentration was performed by spectrophotometric method. Elimination half-life was 58.9 +/- 9.5 h and 30.15 +/- 6.1 h for malnourished and healthy children, respectively. Compared to healthy children, tmax was prolonged in malnutrition group suggesting slow absorption in the latter group. The systemic bioavailability was observed to be higher in protein energy malnutrition. Modifications of the usual dosage regimen in malnutrition are recommended.